Comparing PCI and CABG for heart failure patients with low ejection fraction
Official title: CABG or PCI in Patients With Ischemic Cardiomyopathy - A Randomized Registry Clinical Trial
Run by Vastra Gotaland Region · NCT05329285 · Data updated 2026-11-12
This study is testing whether a less invasive heart procedure called PCI is just as safe and effective as traditional heart surgery, CABG, for patients with heart failure and low heart function.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 470 (estimated) |
| Sponsor | Vastra Gotaland Region Government |
| Locations | 1 site (Gothenburg) |
| Status | Recruiting |
| Started | September 14, 2022 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2052 |
| Registry record updated | October 13, 2026 |
| Trial ID | NCT05329285 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with symptomatic heart failure classified as NYHA class II-IV and an ejection fraction of 40% or less.
✕Probably not a fit
Patients who do not have ischemic cardiomyopathy or those with ejection fractions above 40% may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The STICH-SWEDEHEART trial aims to compare the effectiveness of Percutaneous Coronary Intervention (PCI) versus Coronary Artery Bypass Grafting (CABG) in patients suffering from ischemic cardiomyopathy and reduced left ventricular function. This multicenter, open-label, randomized controlled trial will enroll 470 subjects with multi-vessel coronary artery disease and an ejection fraction of 40% or less. The primary objective is to determine if PCI is non-inferior to CABG in preventing serious complications such as death, stroke, or heart failure hospitalization within three years. The study addresses a critical gap in clinical guidance for treating heart failure patients with significant coronary artery disease.
Why it matters
Potential benefit: If successful, this trial could provide clearer guidance on the best revascularization strategy for heart failure patients with low ejection fraction, potentially improving patient outcomes.
How similar studies have gone: Previous studies have shown varying results in comparing PCI and CABG, but this specific focus on heart failure patients with low ejection fraction is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥18 years. 2. Symptomatic HF defined as NYHA HF class II-IV within 1 month of enrolment 3. LVEF ≤ 40% quantified by either echocardiography or gated SPECT ventriculography, or magnetic resonance (MR) or any other recognized assessment of LVEF 4. Meaningful amount of myocardium at risk because of CAD (BCIS myocardial jeopardy score ≥ 6 on a recent (\> 6 months) coronary angiogram); 5. Heart team believes that a meaningful revascularization can be achieved by both PCI or CABG, with complete revascularization defined as residual ischemia in \<10% of the left ventricle 6. Heart team agrees that guideline directed medical therapy (GDMT) has been initiated for ≥1 month in prevalent and newly diagnosed cases. In patients hospitalized with newly diagnosed iLVSD (with or without acute coronary syndrome (ACS)) requiring revascularization before discharge, GDMT needs to be initiated, when possible, in-hospital before randomization, with the expectation that it will be titrated to maximally tolerated doses after revascularization 7. Written informed consent obtained Exclusion Criteria: 1. Previous randomization in the study 2. Decompensated heart failure requiring inotropic /adrenergic support, invasive or non-invasive ventilation or intra-aortic balloon pump/ventricular assist device therapy less than 48 hours prior to randomization 3. Recent (\<1 month) type 1 myocardial infarction 4. Recent PCI (\<3 months) 5. Valvular heart disease or any other cardiac conditions (e.g. LV aneurysm) requiring surgical repair/replacement 6. Prohibitive bleeding risk or clinical scenario mandating avoidance of long-term dual antiplatelet therapy 7. Expected survival less than 3 years due to non-cardiac illness 8. Circumstances likely to lead to poor treatment compliance 9. Individuals for whom record in public health databases is not accessible (non-eligibility to public health system, parallel healthcare systems 10. Pregnancy or woman of childbearing potential who is not sterilized or using a medically accepted form of contraception
Where it's running
-
Kardiologen
Gothenburg, Sweden Recruiting
Study contacts
- Principal investigator: Björn Redfors, Professor — Sahlgrenska University Hospital
- Study coordinator: Björn Redfors, MD, PhD
- Email: Bjoern.Redfors@wlab.gu.se
- Phone: +46313427543
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.